Connect your agent to akta.pro and build company lists like this across sectors and geos.
Private emerging medical device companies, any stage, ranked by total capital raised. Data compiled .
| Company | Category | Funding | Products & Services | Expansion Signal | Management |
|---|---|---|---|---|---|
| CMR Surgical 🇬🇧 Cambridge Founded 2014 101-250 employees | Surgical Robotics | Funding $1.75B Last raised $400.0M Oct 2026 · Corporate Funded | Designs, manufactures and commercializes modular surgical robotic systems for minimal access surgery, combining robotic hardware, instruments, a visualization system and a digital ecosystem of applications. Versius Surgical Robotic System Versius Plus vLimeLite Versius Connect | M&A Signal A major medtech company took a strategic investment and secured an option to acquire the company, entering soft tissue robotics. | Massimiliano Colella Chief Executive Officer Mark Slack Co-founder and Chief Medical Officer Luke Hares Co-founder and Chief Technology Officer Paul Roberts Chief Commercial and Strategy Officer |
| MiRus 🇺🇸 Marietta Founded 2019 101-250 employees | Orthopedic and Cardiovascular Medical Devices | Funding $1.57B Last raised $1.50B May 2026 · Corporate Funded | Designs and commercializes medical implants and procedural solutions for spine, orthopedic extremity and structural heart applications, built on a proprietary nickel-free molybdenum rhenium superalloy. SIEGEL TAVR EUROPA Pedicle Screw System EUROPA Posterior Cervical Fusion (PCF) System CYGNUS Anterior Cervical Plate System | Regulatory Approval & Product Launch Received FDA 510(k) clearance and commercially launched the IO Expandable Wedge Osteotomy System for foot and ankle surgery in February 2026. | Jay S. Yadav, MD Founder and Chief Executive Officer Mahesh Krishnan Chief Commercial Officer Angela Coldwell Chief Financial Officer |
| BrainCo 🇺🇸 Somerville Founded 2015 101-250 employees | Brain-Computer Interface / Neurotechnology Hardware | Funding $1.55B Last raised $286.4M Jan 2026 · Series Unknown | Develops and manufactures non-invasive brain-computer interface hardware that enables neural control of devices, spanning wellness wearables, bionic prosthetics, autism training systems and humanoid robotics components. OxyZen Easleep FocusCalm Intelligent Bionic Hand | New Product Line Demonstrated a mind-controlled bionic hand driven by its non-invasive neural interface. | Han Bicheng Founder & Chief Executive Officer |
| Neuralink 🇺🇸 Austin Founded 2016 101-250 employees | Brain-Computer Interface / Implantable Neurotechnology | Funding $1.34B Last raised Undisclosed May 2026 · Series Unknown | Develops fully implantable wireless brain-computer interfaces and a surgical robot that let people with paralysis control computers and devices using neural signals in clinical trials. N1 Implant R1 Robot N1 Charger Neuralink Application | New Product Line Demonstrated brain-controlled activation of an AI assistant, phone calls and dictation in a speech-restoration study participant. | Elon Musk Founder & CEO |
| Cornerstone Robotics 🇭🇰 Hong Kong Founded 2019 101-250 employees | Surgical Robotics | Funding $1.18B Last raised $700.0M Sep 2026 · Corporate Funded | Designs, manufactures and sells a full-stack minimally invasive robotic surgery platform for urology, gynecology, general surgery and thoracic surgery, alongside a 4K 3D endoscope. Sentire Endoscopic Surgical Robotic System CV2000 4K 3D Endoscope Sentire Surgical Instruments Professional Surgical Training and After-Sales Service Programs | Ecosystem Buildout Entered a partnership with a global medtech leader that includes a strategic investment. | Samuel Au (欧国威) Founder and CEO Alexis Cheng (郑君乐) Co-Founder & Vice President of Operation and Business Strategy Jerry Wang (王泽睿) Co-Founder, CTO & COO Sophie Hao (郝洹平) Chief Operating Officer |
| Imperative Care 🇺🇸 Campbell Founded 2015 501-1000 employees | Neurovascular and Vascular Thrombectomy Medical Devices | Funding $659.0M Last raised $100.0M Mar 2026 · Convertible Note | Develops and commercializes catheter-based thrombectomy systems that remove clots in stroke, pulmonary embolism and limb ischemia, with aspiration technologies cleared by the FDA. Zoom Stroke System Symphony Thrombectomy System Prodigy Thrombectomy System | New Product Line Received FDA clearance for a thrombectomy system treating pulmonary embolism, extending the portfolio beyond stroke. | Farhad Khosravi Chairman and CEO Nick Hopkins Founder and Executive Director Jay Martin Chief Commercial Officer Matthew Garrett Chief Financial Officer |
| Synchron 🇺🇸 Brooklyn Founded 2016 101-250 employees | Implantable Brain-Computer Interface (BCI) Medical Devices | Funding $605.0M Last raised $275.0M Jun 2026 · Series E | Builds a brain-computer interface implanted through the jugular vein that reads motor-intent signals so paralyzed patients can control computers and smart home devices by thought. Stentrode Endovascular Brain-Computer Interface Chiral Cognitive AI Brain Foundation Model | Clinical Expansion Opened a new early-feasibility clinical study of its investigational Stentrode brain-computer interface for people with severe upper-limb impairment in 2026. | Tom Oxley Founder and CEO Nicholas Opie Co-founder Riki Banerjee Chief Technology Officer Martin Dieck Chairman |
| Kardium 🇨🇦 Burnaby Founded 2007 501-1000 employees | Cardiac Electrophysiology Devices | Funding $502.7M Last raised $31.3M Aug 2026 · Grant | Develops and manufactures an integrated cardiac mapping and ablation platform combining a 122-electrode spherical array catheter, proprietary software and a pulsed field ablation generator. Globe Pulsed Field System Globe Mapping and Ablation System | New Product Line Launched a durability guarantee program for its pulsed field ablation system. | Kevin Chaplin Chief Executive Officer Amos Michelson Co-founder and Chairman Doug Goertzen President and Chief Operating Officer Koert VandenEnden Chief Financial Officer |
| CeQur Simplicity 🇨🇭 Horw Founded 2018 101-250 employees | Wearable Insulin Delivery Devices | Funding $491.6M Last raised $100.0M Jun 2026 · Series E | Develops and manufactures a wearable disposable bolus insulin delivery patch designed to replace mealtime injections for adults with type 1 or type 2 diabetes. CeQur Simplicity Wearable Insulin Patch CeQur Simplicity 1-Unit Dosing Device CeQur Simplicity Inserter | FDA Clearance & Commercial Scale Received FDA clearances for seven-day patch wear and one-unit insulin dosing in June 2026; expanded commercialization efforts. | Bradley Paddock President & Chief Executive Officer Mike Rubino Chief Financial Officer Lisa Furnish Chief Commercial Officer Kim Holdsworth Chief Marketing Officer |
| Distalmotion 🇨🇭 Epalinges Founded 2012 101-250 employees | Surgical Robotics | Funding $460.2M Last raised $70.0M Oct 2026 · Debt Funded | Develops, manufactures and sells a compact mobile soft tissue surgical robot that integrates into any operating room without structural modifications, with a sterile surgeon console. DEXTER Robotic Surgery System Dexter Academy | US Market Expansion Expanded DEXTER robotic surgery indications in the US with an August 2026 FDA clearance for ventral hernia repair; secured financing to support ambulatory surgery center adoption. | Greg Roche Chief Executive Officer Lionel Flaction Co-founder Chas McKhann Executive Chairman Rick Anderson Chairman of the Board |
| Science 🇺🇸 Alameda Founded 2021 101-250 employees | Brain-Computer Interface Medical Devices | Funding $407.3M Last raised $230.0M Mar 2026 · Series C | Develops a wireless subretinal photovoltaic implant that restores central vision in patients with geographic atrophy and builds a broader neuroengineering platform for brain-computer applications. PRIMA Visual Prosthesis Biohybrid Neural Interface Vessel Perfusion Technology Program Science BCI Ecosystem | New Product Line Implanted its vision-restoring retinal chip in the first Stargardt disease patient, extending use beyond age-related macular degeneration. | Max Hodak Founder and CEO Alan Mardinly Co-founder Darius Shahida Chief Strategy Officer Tricia Gugler Chief Financial Officer |
| Precision Neuroscience 🇺🇸 Manhattan Founded 2021 101-250 employees | Brain-Computer Interface Medical Devices | Funding $405.0M Last raised $250.0M Sep 2026 · Series D | Manufactures a non-penetrating thin-film electrode array placed on the brain surface through a minimally invasive micro-slit, using AI software to translate neural activity into commands. Layer 7 Cortical Interface | — | Michael Mager Co-Founder and Chief Executive Officer Benjamin Rapoport Co-Founder and Chief Science Officer Demetrios Papageorgiou Co-Founder Mark Hettick Co-Founder & VP of Engineering - Microfabrication |
| Valgen Medtech 🇨🇳 Hangzhou Founded 2015 101-250 employees | Interventional Cardiology Devices — Structural Heart (Transcatheter Mitral and Tricuspid Valve Repair) | Funding $375.9M Last raised $55.1M Jul 2026 · Secondary Market | Develops and commercializes transcatheter devices for structural heart disease, primarily regurgitation of the mitral and tricuspid heart valves, led by a clip-based repair system. DragonFly™ Transcatheter Mitral Valve Clip System DragonFly-T® Transcatheter Tricuspid Valve Edge-to-Edge Repair System MitralStitch® Transapical Mitral Valve Repair System DragonFire® Transcatheter Myocardial Radiofrequency Ablation System | EU Regulatory Expansion Received EU CE Mark approval in May 2026 for DragonFly treatment of functional mitral regurgitation, extending its European approved indications. | Yiwei Zhao Chief Executive Officer Zhang Tingchao (张廷超) General Manager / Project Chief Scientist |
| MMI 🇺🇸 Jacksonville Founded 2015 51-100 employees | Surgical Robotics — Microsurgery | Funding $354.4M Last raised $125.0M Oct 2026 · Series D | Sells a robotic platform with purpose-built micro-instruments that lets surgeons perform microsurgical procedures on vessels as small as 0.1 millimeters in diameter. Symani Surgical System NanoWrist Scissors and Forceps Robotic Suture Synaptix Digital Surgery Platform | Global Commercial Expansion Raised $125M in October 2026 to expand commercial adoption of the Symani microsurgery system in the US and international markets; reported about 50 installed systems. | Mark Toland Chief Executive Officer Andrew Cleeland Chairman of the Board Giuseppe Prisco President |
| Enable Injections 🇺🇸 Cincinnati Founded 2010 101-250 employees | Wearable Drug Delivery Devices | Funding $352.0M Last raised $30.0M Jan 2026 · Corporate Funded | Makes hands-free mechanical on-body injectors that deliver large-volume drugs and biologics subcutaneously, working with pharmaceutical partners to adapt the platform to their therapies. enFuse Wearable Drug Delivery Platform EMPAVELI Injector ASPAVELI enFuse On-Body Delivery System CirCLIQ On-Body Injector | Ecosystem Buildout A pharmaceutical partner's injector built on its technology won approval in Japan to administer a subcutaneous oncology therapy. | Mike Hooven President and CEO David Kroekel Chief Operating Officer Tim Flaherty Executive Vice President and Chief Financial Officer Matt Huddleston Executive Vice President and Chief Commercial Officer |
A company qualifies when it is a private, operating developer of a medical device for clinical use that is still scaling its commercial footprint: implants, surgical robots, ablation and structural heart systems, neural interfaces and wearable drug-delivery hardware.
The list separates these device makers from software, consumer wellness products, services, pharmaceutical companies and long-established device groups that share the same akta.pro industry code. Across the 15 companies the largest segment by capital is brain-computer interfaces, with $4.31B raised by five companies.
The 15 companies have raised $11.99B in total, and the top three account for $4.87B, or 40.6% of that amount.
Out of scope: public companies, software-only digital therapeutics, consumer wearables, preventive-health services, pharmaceutical companies, long-established device groups, and any company whose last funding predates 2026.
Companies are tagged against standard industry codes and against akta.pro's internal taxonomy, so the same set can be rebuilt by code, by segment, or by a combination of both.
NAICS 334510 Electromedical and Electrotherapeutic Apparatus Manufacturing 339112 Surgical and Medical Instrument Manufacturing 3391 Medical Equipment and Supplies Manufacturing SIC 3841 SURGICAL & MEDICAL INSTRUMENTS & APPARATUS 3845 ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS 3842 ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES Internal taxonomy HLAH Medical Devices & DiagnosticsIndustry codes are provided for cross-referencing against public filings and procurement records. akta.pro classification is independent of them, so a company may carry an internal segment without a matching NAICS or SIC registration.